Just the usuall trash. Every time we started moving up it
Just the usuall trash. Every time we started moving up it would be knocked down. I didn't pay too much attention to anything but the ticker. Just the same games the MM's have been playing.
People don't understand that the mm's won't stop these games until the buying pressure comes in. The price right now means nothing. Because we don't yet have the eyes on us that we need.
People want to ask, "well if were leading up to an event, why is the pps not ramping up?"
When a stock "ramps up" in anticipation of a big event/news. This is because there are already a lot of eyes on the company and the shareholders are excited. This event we are headed into is for the purpose of putting us into the spotlight. We arn't there yet, and people don't know we exist let alone take us seriously.
IMO we won't see this start to gain traction unless we have some really solid news from the event, forward looking statements and heavy press. The news and implementation of this CBD product ABSOLUTELY HAS TO BE OF SUBSTANCE.
all IMO
Inergetics Inc. (NRTI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...
Continue Reading
Lighting a Fire Under Complacency Elections often bring out the big dogs, but rarely do you see a grassroots campaign like Extreme Weather Survivors’ 'Stolen Summers' making such ripples. Rallying from New York to North Carolina and everywhere in between, this campaign has been a clarion call for communities ravaged by Mother Nature's fury. And let's face it, the...
Continue Reading
Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...
Continue Reading
A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...
Continue Reading
Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...
Continue Reading
Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...
Continue Reading
SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...
Continue Reading
MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....
Continue Reading
The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...
Continue Reading
A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...
Continue Reading
Top 5 Most Recently Viewed Articles
A Cemented Alliance in Aerospace It ain't every day you see a partnership like this get fortified. Alleima, the Swedish heavyweight in metal solutions, is securing its bond with aviation giant Airbus. This isn’t some flash-in-the-pan fling; this is about titanium seamless tubes powering those shiny flying machines and elevating the aerospace game. The Backbone of a...
Continue Reading
Important Update for Sable Offshore Investors Sable Offshore Corp. (SOC), a prominent player in the oil transportation industry, is currently entangled in legal proceedings that have implications for its investors. If you've invested in SOC and suffered losses exceeding $100,000, there are critical updates you need to be aware of. Details on the Class Action Lawsuit A...
Continue Reading
Srini Rajamani Appointed as CEO of Opus Technologies Opus Technologies, a pioneer in payment solutions, has announced the leadership transition to Srini Rajamani as the new Chief Executive Officer. His appointment becomes effective immediately, succeeding Praveen TM, who will remain an integral part of the leadership team. Innovative Leadership and Experience Srini...
Continue Reading
PacBio's New Collaboration for Cancer Research Pacific Biosciences (NASDAQ: PACB), commonly referred to as PacBio, has recently entered an exciting partnership with the National Cancer Centre Singapore (NCCS). This Research Collaboration Agreement (RCA) aims to push the boundaries of cancer research in Asia, utilizing state-of-the-art sequencing technologies. Innovative...
Continue Reading
Oriental Rise Holding Limited Celebrates IPO Success Ningde, China - Oriental Rise Holding Limited, also known simply as "Oriental Rise" (NASDAQ: ORIS), has marked a momentous event in its journey by successfully closing its initial public offering (IPO). The offering, which involved 1,750,000 ordinary shares priced at $4 each, demonstrates the growing interest in the...
Continue Reading